AFFIRM-AHF-based multinational cost-effectiveness analysis of intravenous ferric carboxymaltose for the treatment of iron deficiency in an acute heart failure setting
Vericiguat in patients with atrial fibrilation and heart failure with reduced ejection fraction: insights from the VICTORIA (VerICiguaT global study in subjects with HFrEF)